➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Litigation Details for TEVA PHARMACEUTICALS USA, INC. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2014)

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in TEVA PHARMACEUTICALS USA, INC. v. Mylan Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for TEVA PHARMACEUTICALS USA, INC. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-10-07 1 of United States Patent No. 8,232,250 (“the ’250 patent”) and United States Patent No. 8,399,413 (“the… #: 11 COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 8,232,250 BY DEFENDANTS 69. The allegations of the…DECLARATORY JUDGMENT OF INFRINGMENT OF U.S. PATENT NO. 8.232.250 BY DEFENDANTS 84. The allegations of the…copy of the ’250 patent is attached as Exhibit A. The ’413 Patent 53. The ’413 patent, entitled “Low … ’413 patent. 56. Teva Ltd. is the exclusive licensee of the ’413 patent. 57. The ’413 patent is listed External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.